Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Roadmap Capital Takes a Passive Stake at IntelGenx Worth 11.8%

Roadmap Capital, IntelGenx: Just now, the newly founded Roadmap Capital reported it is establishing a position in IntelGenx Technologies Corp. (OTCMKTS:IGXT). In a filing with the SEC, Roadmap disclosed a passive stake that comprises over 6.2 million shares of the company, worth almost $3.3 million, at the current share price of IntelGenx. The position represents around 11.8% of the company.

Roadmap Capital has been founded by the former vice-president and portfolio manager at the Canadian-based hedge fund BluMont Capital.


Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!